The sleep apnea implants market is estimated at USD 480.6 million in 2026, is projected to reach USD 697.8 million by 2036 and is forecast to register a 3.8% CAGR between 2026 and 2036. In 2026, hypoglossal neurostimulation devices hold 60.0% of the product type category and obstructive sleep apnea represents 87.0% of indication demand.